Search
Cardiolipin Biosynthesis CL(a-13:0/i-24:0/a-21:0/a-25:0)[rac]
smpdb.ca/view/SMP0493454MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Cardiolipin Biosynthesis CL(a-13:0/i-24:0/a-25:0/a-25:0)[rac]
smpdb.ca/view/SMP0493575MetabolicLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.
Clonazepam
go.drugbank.com/drugs/DB01068ApprovedIllicitInvestigational[FDA Label][A175438,A175441,L5572,F3763,F3787,F3796] Since being first patented in 1960 and then released for sale from Roche in the US in 1975,[T469,T472] clonazepam has experienced a storied history … Now available as a generic medication, the agent continues to see exceptionally high use as millions of prescriptions are written for the medication internationally every year.
Synonyms: 5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one, 5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-oneCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2E1 InhibitorsNitric oxide reductase
go.drugbank.com/bio_entities/BE0002576TargetMoorella thermoacetica (strain ATCC 39073)Has nitric oxide reductase activity in combination with Hrb; probably involved in nitrosative stress protection.
Synonyms: Flavoprotein A, Type A flavoprotein FprAIvabradine
go.drugbank.com/drugs/DB09083ApprovedInvestigationalIvabradine acts by selectively inhibiting the "funny" channel pacemaker current (If) in the sinoatrial node in a dose-dependent fashion, resulting in a lower heart rate and thus more blood to flow to the … Therefore, as ivabradine is designed as a "pure" heart rate-lowering drug by selectively acting on the If channels, it may offer a more favorable side effect profile due to its lower likelihood of causing
Synonyms: 3-[3-({[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-oneMixtures: CARIVALAN 25/5, CARIVALAN 6.25/5Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/a-13:0)
smpdb.ca/view/SMP0043341DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/a-15:0)
smpdb.ca/view/SMP0043342DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/a-17:0)
smpdb.ca/view/SMP0043343DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/a-13:0)
smpdb.ca/view/SMP0043359DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.
Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/a-15:0)
smpdb.ca/view/SMP0043360DiseaseLast, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor. … Newly synthesized cardiolipins undergo remodeling, a process carried out by the enzyme tafazzin.